Original air date: March 2nd 2025 Today we begin with a sea change in America’s framework for conducting experiments on humans. The biggest surprise is— you probably know little to nothing about it. It surrounds with a provision tucked into […]
The following information is from Public Citizen. Public Citizen, a nonprofit consumer advocacy organization, is calling for federal officials to investigate troubling practices in recent Alzheimer’s disease drug trials. A New York Times report reveals that participants in trials for two drugs—lecanemab
Patients in Alzheimer’s Drug Trials Not Told About Risks Read More »
The following is from Children’s Health Defense. Nirsevimab, marketed by Sanofi and AstraZeneca as Beyfortus is a drug developed to protect infants from RSV (respiratory syncytial virus), a virus that can lead to serious respiratory infections. It was fast-tracked for approval by the US
(READ) FDA fast-tracked RSV shot linked to infant deaths Read More »
The following is from The Vaccine Reaction. On June 8, 2023, the U.S. Food and Drug Administration’s (FDA) Antimicrobial Drugs Advisory Committee (AMDAC) voted unanimously (21-0) in favor of AstraZeneca and Sanofi’s new nirsevimab (Beyfortus) monoclonal antibody drug believed to
12 infant deaths reported in clinical trials for FDA-endorsed RSV drug Read More »
The following is an excerpt from The Vaccine Reaction. 86 Percent of Clinical Trials Funded by Big Pharma John Abramson, MD has stated that medical students and doctors are being taught the importance of using results of clinical trials to
Large percentage of clinical trials funded by ‘Big Pharma’ Read More »
